Corporate announcement
28 July 2021
Global healthcare knowledge provider, BMJ, continues to drive open access to medical research with new multispecialty journal, BMJ Medicine
BMJ Medicine's mission is to create a healthier world through the publication of influential multispecialty medical research, reviews, and commentary, which have the potential to change practice or policy and improve public health and patient outcomes.
Fully launching in October 2021, BMJ Medicine will promote multidisciplinary discussion and debate suited to a broad international scientific and clinical readership.
In a world where people live longer with more complex comorbidities and where social determinants of health are leading to greater disparity in health outcomes, BMJ Medicine will create opportunities for interdisciplinary and transdisciplinary conversations, and work in partnership with patients and the public to improve health.
Closely aligned with BMJ's flagship journal, The BMJ, BMJ Medicine will adopt the values, editorial standards and author service for which The BMJ is renowned. It will offer a trusted open access home for multispecialty research, including research based on new and emergent methodologies.
BMJ Medicine will also publish articles on topical issues in statistics and research methods and reporting and in depth specialist reviews that focus on mechanisms of disease and the latest diagnostic and therapeutic advances.
At BMJ, we are committed to partnering with patients and the public. We believe this is the only way to ensure that medical journals are relevant, practical, and clinically impactful. BMJ Medicine will promote co-production of research and educational content, and articles will be reviewed by patients alongside traditional peer review. We will also work closely with The BMJ's patient editor team and the broader patient community to continually develop our policies, processes and content.
